After implantation of NSCLC cells in nude mice, they treated mice with anti-mouse PD-1 antibody and observed an increased tumor growth compared with control, and enrichment in tumor micro-environment by macrophages similar to what they observed in hyperprogressive patients. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.